LPL Financial LLC

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1403438 FORT MILL, SC

Position in ALLO

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$458,993

+$38,703 QoQ

Shares Held

220,670

+28.1% QoQ

Ownership

0.064%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#76

of 209 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. ALLO ranks #103 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$458,993	220,670	+28.1%	Shares	Sole	2026-08-07
2026-03-31	$420,290	172,250	+0.9%	Shares	Sole	2026-05-06
2025-12-31	$233,927	170,750	-3.8%	Shares	Sole	2026-02-11
2025-09-30	$220,100	177,500	+2.0%	Shares	Sole	2025-11-12
2025-06-30	$196,578	173,963	+1.3%	Shares	Sole	2025-08-12
2025-03-31	$250,700	171,713	+14.2%	Shares	Sole	2025-05-07
2024-12-31	$320,379	150,413	-1.0%	Shares	Sole	2025-02-11
2024-09-30	$425,320	151,900	+21.0%	Shares	Sole	2024-11-08
2024-06-30	$292,589	125,575	+51.1%	Shares	Sole	2024-08-07
2024-03-31	$371,546	83,120	+10.2%	Shares	Sole	2024-05-10
2023-12-31	$242,098	75,420	+98.4%	Shares	Sole	2024-02-14
2023-09-30	$120,482	38,007	+82.3%	Shares	Sole	2023-11-13
2023-06-30	$103,624	20,850	—	Shares	Sole	2023-07-31
No filing history on record for this holder in this stock.